Volume 12, Issue 2 (Scientific Journal of Hamadan University of Medical Sciences-Summer 2005)                   Avicenna J Clin Med 2005, 12(2): 68-71 | Back to browse issues page

XML Persian Abstract Print


, m_mazdeh@hotmail.com
Abstract:   (4280 Views)

Introduction : There are several introduced forms of treatment for patients with relapse-remitting & secondary progressive multiple sclerosis in recent years. Interferon beta-1b (Betaferon) is the first of these agents that administered subcutaneously once in every two days.

Case Report: This report is related to a 33 years old female. After 6 times of Betaferon injection vasculitis necrotizing was occurred with perforated ulcer (3´3.5 cm) on the Lt side prox. lower limb . Simultaneoulsly ulcer (0.5´0.5 cm) on the Lt side prox. upper limb , small ulcer (1´1 cm) on the Rt side prox. lower limb and erythemia on the Rt side prox. upper limb around injection site.

Conclusion: Betaferon was stopped to ensure ulcers is healed. The patient showed improvement after 3 months without debridment. It is recommended to proceed with the above plan until complete recovery is achieved.

Full-Text [PDF 200 kb]   (3142 Downloads)    
Type of Study: Case Report | Subject: Other Clinical Specialties

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.